StemCell Institute Inc.

7096

JP3399640006

Healthcare Facilities & Services

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-23 am EDT			5-day change	1st Jan Change
1,740 ^JPY	-1.75%		-4.92%	-18.84%

2023	Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.	CI
2023	Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023.	CI

StemCell Institute Inc. has withdrawn its IPO.

March 23, 2020 at 12:00 am EDT

StemCell Institute Inc. has withdrawn its IPO. Security Name: Common Stock Security Type: Common Stock Securities Offered: 829,300 Transaction Features: Sponsor Backed Offering

Latest news about StemCell Institute Inc.

Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.	Dec. 22	CI
Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023.	23-09-23	CI
Cuorips Inc. has completed an IPO in the amount of Â¥3.432 billion.	23-06-27	CI
Cuorips Inc. has filed an IPO.	23-05-23	CI
Certain Common Stock of StemCell Institute Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2021.	21-12-20	CI
Certain Common Stock of StemCell Institute Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2021.	21-09-21	CI
StemCell Institute Inc. has completed an IPO in the amount of ¥2.32624 billion.	21-06-25	CI
StemCell Institute Inc. has filed an IPO.	21-05-21	CI
CUORiPS Inc. announced that it expects to receive ¥2 billion in funding from Asahi Intecc Co., Ltd., StemCell Institute Inc., Dai-Dan Co., Ltd., Taiko Pharmaceutical Co.,Ltd., Kyoto University Innovation Capital Co., Ltd., Terumo Corporation and other investors	20-12-03	CI
StemCell Institute Inc. has withdrawn its IPO.	20-03-23	CI
StemCell Institute Inc. has filed an IPO.	20-03-05	CI
TrimGen Holdings Co., Ltd completed the acquisition of 56.57% stake in StemCell Institute Inc. from Nihon Trim Co., Ltd..	15-03-30	CI
TrimGen Holdings Co., Ltd agreed to acquire 56.57% stake in StemCell Institute Inc. from for Nihon Trim Co., Ltd. approximately ¥940 million.	15-03-18	CI
Nihon Trim Co., Ltd. completed the acquisition of 50.1% stake in Stemcell Institute from Kunimatsu Yamamoto and funds sponsored by Japan Asia Investment Co. Ltd., JAFCO Co., Ltd. and Ant Capital Partners Co., Ltd.	13-09-25	CI
Nihon Trim Co., Ltd. agreed to acquire a 50.1% stake in Stemcell Institute from Kunimatsu Yamamoto and funds sponsored by Japan Asia Investment Co. Ltd., JAFCO Co., Ltd. and Ant Capital Partners Co., Ltd. for approximately ¥790 million.	13-09-09	CI

StemCell Institute Inc is mainly engaged in the cell bank business, which separates and stores cord blood. The Company operates cell bank business from umbilical cord blood and umbilical cord, development of new treatment methods and regenerative medicine products, regenerative medicine and fertility treatment, business development and investment in childbirth and childcare areas. The Company operates Cell Bank business segment. After signing the contract for the separation and storage of umbilical cord blood with customers (pregnant women), the umbilical cord blood collected at domestic umbilical cord blood collection cooperative hospitals (university hospitals, obstetric clinics and others) is collected, and carried into its cell processing center in Minato-ku, Tokyo and Midori-ku, Yokohama. It is stored at its cell storage center (Midori-ku, Yokohama, Kanagawa) for a long time at ultra-low temperature after stem cells contained in cord blood being separated, extracted and prepared.

Sector

Healthcare Facilities & Services

Calendar

2024-07-31 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for StemCell Institute Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
STEMCELL INSTITUTE INC.	-18.84%	116M
HCA HEALTHCARE, INC.	+16.49%	83.4B
CVS HEALTH CORPORATION	-29.52%	72.11B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	27.04B
LABCORP HOLDINGS INC.	-13.29%	16.96B
FRESENIUS SE & CO. KGAA	+1.03%	16.86B
QUEST DIAGNOSTICS INCORPORATED	+1.57%	15.76B
NATERA, INC.	+71.63%	13.33B
REDE D'OR SÃO LUIZ S.A.	+1.53%	12.76B
TENET HEALTHCARE CORPORATION	+70.68%	12.74B

Other Healthcare Facilities & Services